The Alcohol and Drug Awareness Council (ADAC) in Lufkin is set to lose roughly $400,000 in grants and state funding, ...

GoodRx Holdings, Inc. ( GDRX) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx Third Quarter 2025 Earnings Call. As a ...

Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata” or the "Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other ...

Inclusion in the ENDO 1000 study in the UK for multiple sample types is presented as evidence of market validation for OraSure Technologies' collection kits, as described in the Q3 2025 earnings call, ...

Viridian Therapeutics, Inc. , a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today announced the ...

This article provides insights into patterns of health care use following emergency department visits by high-need, high-cost patients with different types of California Medicaid primary care ...

The state’s correctional system seems intent on putting itself out of business. The maximum-security MCI-Cedar Junction facility in Walpole closed in 2023, while in 2024, both the medium-security ...

The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly ...

The “Alpha Arena” pits the six most popular artificial intelligence programs in a crypto-trading competition to see which is independently smart enough to master the market and ...

Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and ...

New preclinical data for PM577 in Wilson’s Disease (WD) to be presented at AASLD; on-track to file IND and/or CTA in H1’26, ...

The Foundation for Opioid Response Efforts (FORE) today announced five new grants totaling more than $2 million to support collaborative strategies addressing the nation’s opioid and overdose crisis.